Nitrazepam Lph (Nitrazepam)

Nitrazepam binds to the benzodiazepine site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride ion channel opening when GABA binds, leading to greater neuronal inhibition. The result is a calming effect that facilitates sleep, reduces anxiety, and can suppress seizure activity.

The appropriate dose of Nitrazepam Lph is determined by the prescribing clinician based on the patient’s age, medical condition, and response to therapy. Dosage may vary for insomnia, anxiety, or seizure control, and the prescriber will provide specific instructions tailored to the individual.

Safety of nitrazepam in pregnancy and lactation has not been definitively established. It is generally classified as contraindicated or to be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nitrazepam belongs to the benzodiazepine class, offering rapid onset of sleep and strong sedative properties. Compared with non‑benzodiazepine hypnotics (e.g., zolpidem or zaleplon), nitrazepam may have a longer half‑life and a higher risk of next‑day sedation, dependence, and withdrawal. Choice of agent depends on patient factors, treatment duration, and risk‑benefit assessment.

Nitrazepam Lph tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister or bottle, protect from moisture, heat, and direct sunlight. Do not store in bathrooms or near kitchen appliances. Keep out of reach of children.

Nitrazepam Lph is taken orally, usually with a glass of water. The tablet is swallowed whole and should be taken as directed by the prescriber, often shortly before bedtime for insomnia or at the prescribed time for anxiety or seizure control. Do not crush or chew unless specifically instructed.

Serious risks include respiratory depression, especially when combined with other depressants, severe hypotension, paradoxical reactions such as agitation or aggression, dependence and withdrawal syndrome, and rare but life‑threatening skin reactions. Patients should be monitored closely for these events, and the medication should be discontinued if they occur.

Nitrazepam is contraindicated in individuals with known hypersensitivity to benzodiazepines, acute narrow‑angle glaucoma, severe respiratory insufficiency, and those who are currently abusing alcohol or other central nervous system depressants. Caution is also advised for patients with severe hepatic impairment, myasthenia gravis, or a history of severe depression or suicidal thoughts.